MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 80 filers reported holding MIRATI THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 71.83 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,046,665 | +45.3% | 46,985 | +20.5% | 0.00% | – |
| Q2 2023 | $1,408,745 | -5.8% | 38,991 | -3.1% | 0.00% | -100.0% |
| Q1 2023 | $1,495,938 | -6.1% | 40,235 | +14.4% | 0.00% | 0.0% |
| Q4 2022 | $1,593,054 | -37.1% | 35,159 | -3.0% | 0.00% | 0.0% |
| Q3 2022 | $2,532,000 | -1.8% | 36,255 | -5.6% | 0.00% | 0.0% |
| Q2 2022 | $2,578,000 | -19.0% | 38,397 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $3,181,000 | -40.3% | 38,691 | +6.5% | 0.00% | -50.0% |
| Q4 2021 | $5,331,000 | -19.4% | 36,338 | -2.8% | 0.00% | 0.0% |
| Q3 2021 | $6,616,000 | +40.8% | 37,401 | +28.5% | 0.00% | 0.0% |
| Q2 2021 | $4,700,000 | -0.2% | 29,095 | +5.9% | 0.00% | 0.0% |
| Q1 2021 | $4,709,000 | -23.4% | 27,487 | -1.8% | 0.00% | 0.0% |
| Q4 2020 | $6,151,000 | +63.0% | 28,001 | +23.2% | 0.00% | 0.0% |
| Q3 2020 | $3,774,000 | +45.4% | 22,723 | -0.0% | 0.00% | +100.0% |
| Q2 2020 | $2,595,000 | +57.4% | 22,728 | +6.0% | 0.00% | 0.0% |
| Q1 2020 | $1,649,000 | -27.0% | 21,450 | +22.4% | 0.00% | 0.0% |
| Q4 2019 | $2,259,000 | +76.1% | 17,530 | +6.5% | 0.00% | 0.0% |
| Q3 2019 | $1,283,000 | +144.4% | 16,463 | +223.2% | 0.00% | – |
| Q2 2019 | $525,000 | +75.6% | 5,093 | +24.6% | 0.00% | – |
| Q1 2019 | $299,000 | +94.2% | 4,089 | +12.5% | 0.00% | – |
| Q4 2018 | $154,000 | +4.8% | 3,635 | +16.5% | 0.00% | – |
| Q3 2018 | $147,000 | -2.0% | 3,120 | +2.6% | 0.00% | – |
| Q2 2018 | $150,000 | +689.5% | 3,042 | -19.7% | 0.00% | – |
| Q1 2017 | $19,000 | +5.6% | 3,790 | 0.0% | 0.00% | – |
| Q4 2016 | $18,000 | +20.0% | 3,790 | +70.0% | 0.00% | – |
| Q3 2016 | $15,000 | +25.0% | 2,230 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | -75.0% | 2,230 | 0.0% | 0.00% | – |
| Q1 2016 | $48,000 | -30.4% | 2,230 | 0.0% | 0.00% | – |
| Q4 2015 | $69,000 | – | 2,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |